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Patterning Vasculature: The Role of Biofabrication to Achieve an
Integrated Multicellular Ecosystem
Afonso Malheiro,† Paul Wieringa,† Carlos Mota, Matthew Baker, and Lorenzo Moroni*
Department of Complex Tissue Regeneration, MERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht
University, 6211 LK Maastricht, The Netherlands
ABSTRACT: In regenerative medicine (RM), creating engineered
tissues with functionally relevant vasculature is a critical goal. Recent
technological advances in biofabrication and bioprinting have been
reported which present significant steps toward achieving this aim. While
many approaches to address this challenge derive from microfabrication
techniques, progress in the material science field and 3D printing
technologies fields have introduced exciting new possibilities for the
creation of increasingly complex and functional vascularized tissues. Here,
we provide a brief overview of the process of vascularization and its
importance within the fields of RM and tissue engineering (TE). We give
a brief synopsis of various strategies that have been reported to induce
cell patterning for a designed vascular network within a TE construct,
including material-based strategies, structural molding approaches, and
direct cell-patterning techniques. As well as highlighting advances in the field, we discuss possible areas for further development;
in particular, we advocate a combination of strategies to successfully overcome current limitations in developing functional
artificial tissues. Overall, the technological innovations in new bioprinting approaches and complementary progress in materials
development are recognized as having critical roles as TE matures toward broadly applicable, clinically relevant applications.
KEYWORDS: tissue engineering, vascularization, multicellular architectures, bioprinting, multiscale patterning
■ INTRODUCTION
The development and improvement of biofabrication techni-
ques have enabled substantial advances in the field of RM.
Three-dimensional (3D) biomimetic and patient-specific
constructs can now be designed with the aim to fully restore
a damaged tissue’s functionality.1 Although progress toward
larger tissue replacements has been made, the inclusion of
functional vasculature within these constructs to maintain cell
viability is still a great challenge facing the biofabrication/TE
field. For this reason, the clinical translation of lab-grown
tissues remains limited to thin tissues, such as skin and
bladder,2−5 which can survive through avascular diffusion of
nutrients and oxygen. To transplant thick tissues, the
engineered construct must be prevascularized to remain viable,
functional, and quickly integrate with the host.6
Biofabrication technologies is a promising avenue to address
the challenge of prevascularization.7−9 Methods such as 3D
printing of solid polymers, electrospinning, and stereolitog-
raphy depend on scaffolds, from natural or synthetic origin, to
serve as temporary support for seeded cells, whereas the tissue
is forming and maturing. Engineering vascularization within
such TE constructs is complicated by the random manner in
which cells are seeded and populate the scaffolds. Alternate
approaches develop a modular construct by controlled
assembly of smaller tissue building blocks. The motivation of
these techniques is to mimic the native tissue architecture by
directing cell organization, for instance through structures
designed to guide cellular self-assembly. Examples of such
technologies include 3D bioprinting, inkjet printing, and live
cell lithography. Approaches that achieve vascular tissue
patterning enable the creation and study of vascular networks
through the spatial control over vessel formation.
Patterning capability is an asset not only for improved
vascularization but also as we progress toward multicellular
systems that can yield functional tissues or complex organ
models. Constructs composed of functional cells, the
parenchyma, and supporting cells, the stroma, can be
sequentially assembled together with the endothelium in
order to achieve the multilayered architectural context of an
organ.10 Additionally, nerve tissue could also be supplied to the
construct, which would permit the study of neurovascular
interactions. Considering that a full functional tissue is only
achieved when innervated,11 the combination of a vascular and
neural network in a single platform is a significant advance
toward a true representation of an organ microenvironment.
Likewise, organoids can also greatly benefit from the
presence of vasculature. These miniaturized versions of organs
provide accurate anatomical replicas and constitute powerful
tools for in vivo simulations, such as drug response. However,
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perfusion is required to emulate the dynamic mechanistic
environment of cells.12 Furthermore, the maturation of
progenitor cells used to generate organoids often requires
blood flow for the transportation of biochemical cues, such as
paracrine signals, which are responsible for establishing
communication between cells. In the case of renal organoids,
for example, sustained circulation allows the cells to mature and
gain functionality in terms of absorption, secretion, and
filtration.13,14
With these potential applications, strategies to engineer
vascularization are a major research focus in the field of
biofabrication. Advances in this area may thus address the
current limitations of TE,15 unlocking the viable fabrication of
complex and large implants and contributing to our under-
standing of synergistic multicellular systems. Here, we provide
an overview of biofabrication approaches to create vascular
networks as well as discuss the latest developments with a focus
on patterning techniques. As summarized in Figure 1, we have
categorized approaches to control the development of vascular
networks as
• material-induced patterning, guidance of vessel growth
through the selective presentation of physicochemical
cues, such as cell adhesion peptides, growth factors,
protease-sensible cross-links and/or cross-linking density,
to cells within a biomatrix
• structure-induced patterning, two-step biofabrication
processes that consist of the construction of vessel-like
architectures through additive or subtractive manufactur-
ing and further lining with endothelial cells
• direct cell patterning, use of micromolding or printing
techniques to assemble vessels by deposition of vascular-
specific cells into defined locations
We also consider the limitations inherent to the above-
mentioned strategies and discuss recent research that aims at
tackling these. Finally, some prospects regarding vascular
integration within a multicellular ecosystem, multiple length
scales needed for functional vascularization, and future
expectations of organ development are also discussed.
■ BIOLOGICAL PROCESSES AND REQUIREMENTS
In the absence of a capillary network, an implant will rely on
diffusional processes for the supply of oxygen and nutrients as
well as the removal of metabolites. However, implants of
clinically relevant size normally exceed the diffusion limit
(approximately 200 μm), leading to the development of a
necrotic core and failure to integrate with the host tissue.16,17,8
Therefore, the long-term survival of an avascular cell-laden
construct strongly depends on rapid neovascularization, the
formation of new blood vessels.18 An alternative approach is to
engineer a vascular network within the tissue implant, which
requires a deep understanding of the well-orchestrated natural
processes that lead to vessel formation and remodeling. A
thorough description of these processes can be found in
literature.19−22
Figure 1. Overview of the classical biofabrication approaches to achieve and pattern vasculature in a TE construct. (a) Spontaneous and uncontrolled
self-assembly of vessels from randomly seeded endothelial cells within a bulk hydrogel. (b) Photopatterning of physicochemical cues, for instance,
cell adhesion peptides (e.g., RGD), growth factors (e.g., VEGF) and protease-sensible cross-links (e.g., MMP-sensible cross-links) for vessel growth
guidance. (c) Vascular channel formation through the removal of a channel template within a hydrogel and subsequent endothelialization (e.g.,
perfusion with endothelial cells). (d) Bioprinting of cellular spheroids into a biocompatible support (e.g., collagen hydrogel). The spheroids will fuse
automatically and self-assemble into vascular structures. (e) Combination of biofabrication approaches to produce a vascular network with multiscale
dimensions and clear perfusion accesses. The larger vessel with an inlet/outlet could be fabricate through structure-induced patterning techniques.
Smaller vessels emanating from the parent vessel could be produced by direct cell patterning techniques and would provide a bridge to a microvessel
pattern achieved through material-induced patterning strategies.
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During early embryonic development, de novo formation of
blood vessels is achieved through the differentiation of
mesodermal progenitor cells in a process termed vasculo-
genesis. Initially, hemangioblasts located on the yolk sac form
focal aggregations designated by blood islands. Within these
structures, cells located in the periphery will differentiate into
angioblasts, while those in the center will originate
hematopoietic cells. Migrating angioblasts self-assemble into
aggregates, proliferate, and finally differentiate to form the
primary vascular plexus.22,23 Postnatal vasculogenesis can also
occur during tumor growth or revascularization of damaged
tissue, via circulating endothelial progenitor cells (EPCs). This
subtype of CD34/VEGFR-2-positive bone marrow-derived
angioblasts can be recruited to specific areas and differentiate
for in situ vessel growth, in a process promoted by vascular
endothelial growth factor (VEGF) and basic fibroblast growth
factor (bFGF).22,24
In another neovascularization process, angiogenesis forms
blood vessels from pre-existing ones; it is the main mechanism
during embryogenesis (following creation of the vascular
plexus) and adult life. New vessels can be formed from
sprouting endothelial cells (sprouting angiogenesis) or through
the splitting of other vessels (intussusceptive angiogenesis).23,24
We focus on the former process here because it is more
relevant to the integration of implants within the host
vasculature. Sprouting angiogenesis initiates in response to
pro-angiogenic signals that are secreted by local tissues
according to their oxygen and nutrient demands. In hypoxic
conditions, cells are induced to secrete VEGF, leading to
endothelial cell activation and liberation from their matrix
support via proteolytic degradation (through secretion of
matrix metalloproteinases, MMPs).25,19 Subsequently, the
Notch pathway controls the specification of endothelial cells
into tip or stalk cells via a Notch/DLL4 feedback loop.19 Tip
cells will lead the sprouting process by sensing their
surroundings with filopodia, guiding the sprout via attractive
or repulsive signals.26 Endothelial cells in close contact will then
form a lumen by coalescence of intracellular vacuoles, and new
vascular cords are created as soon as migrating neighbor tip
cells fuse together. These new vessels remain immature and
need to undergo further stabilization steps to become
functional. First, perfusion begins by re-establishing a quiescent
endothelial phenotype and reshaping the new vessels
connections, which are further strengthened by the formation
of adherent and tight junctions. Next, maturation steps involve
mural cell recruitment and extracellular matrix (ECM)
deposition. Pericytes, attracted by the endothelial platelet-
derived growth factor (PDGF), are recruited to capillaries and
adhere to them via the angiopoietin 1 action (ANG1).19 For
arteries and veins, smooth muscle cells (SMCs) are the
stabilization effectors in a process promoted by transforming
growth factor β (TGF-β).27 To complete maturation, we
remodeled vessels as a consequence of fluid flow shear stress,
which leads to increased diameter and wall thickness (arterio-
genesis).24
Because of this intricate sequence of events, both vasculo-
genesis and angiogenesis are slow processes. Thus, host
endothelial cell invasion is often not fast enough to promote
vascularization within a large implant before its failure.18 For
this reason, efforts have been made to initiate these
vascularization processes within TE constructs prior to
implantation to maintain viable tissue of a clinically relevant
size. These endeavors, however, require a veritable source of
endothelial cells. Mature cells, such as human umbilical vein
endothelial cells (HUVECs) or human microvascular endothe-
lial cells (HMVECs), have been widely researched for this
purpose.25,28−30 These cells can be easily collected from the
umbilical cord or by skin biopsy, respectively, and are relatively
simple to culture, forming vascular networks both in vitro and
in vivo.30 However, expansion of mature cells to sufficient
quantity can be a limiting factor due to their low proliferation
rate. In comparison, EPCs exhibit an increased proliferation
potential and survival rate when compared to their mature
counterparts.30,31 Late-outgrowth EPCs, also known as
endothelial colony−forming cells (ECFCs), participate in
tubulogenesis in vitro and have been shown to lead to an
accelerated anastomosis in a coculture with fibroblasts when
compared to HUVECs.32 Large expansion of these cells is a
drawback, however, because of the high incidence of
cytogenetic alteration.30 The other EPCs subtype, the early
EPCs, do not form vascular networks but can also contribute to
neovascularization through paracrine signals.18,31
Vessel maturation and long-term stability are dependent on
the addition of supporting cells to the system. Pericytes and
SMCs are obvious cell choices, but others such as mesenchymal
stem cells (MSCs) and fibroblasts, have been reported to
display pericyte-like behavior.33,34 Fibroblasts, mostly of dermal
origin, have already been successfully cocultured with
HUVECs,25 HMVECs,29 and EPCs,32 demonstrating their
versatility. In comparison with SMCs and MSCs, fibroblasts
(derived from human dermis and mouse 10T1/2 cell line)
promoted the formation of a denser vascular network over a 28-
day culture period with HUVECs.35
■ PRIOR ART: STANDARD APPROACHES
To better understand vascular formation, numerous in vitro
models have been developed (for a review, see Goodwin36).
Endothelial cells were initially grown on flat substrates of either
tissue-culture plastic or on hydrogel surfaces and served to
highlight important factors that simulate vasculogenesis and
vascular morphogenesis, such as ECM components (i.e.,
laminins) and the pro-vascularization factors VEGF and
bFGF.36 In lieu of the presence of growth factors, cocultures
with suitable mural cells have also been able to stimulate
endothelial cells to form vascular networks.37
Because two-dimensional (2D) substrates intrinsically limit
the formation of 3D vascular structures, researchers began to
encapsulate cells within hydrogels of reconstituted ECM
proteins to better approximate the protein composition and
3D environment found in vivo (Figure 1, top panel).
Proteinaceous gels made from collagen, fibrin, or Matrigel (a
tumor-derived ECM) have been critical in initiating the
vascularization processes within a 3D context. Synthetic
hydrogels can also support vessel formation, but they must
emulate natural ECM materials in terms of being cell adhesive,
sufficiently soft, and susceptible to cellular remodeling to allow
for cell migration and self-assembly of vasculature.38
When in vitro vascularization is initiated with appropriate 3D
environments, vascular formation is more comparable to that of
the in vivo state.39 Furthermore, endothelial cells grown in 3D
exhibit enhanced matrix-remodeling capabilities, a critical
mechanism in angiogenesis.40 Compared to 2D substrates,
3D environments can also stimulate endothelial cells from a
wider variety of sources to form capillaries,41 and the resulting
networks are stable for a longer period of time. However,
similar to the 2D culture systems, endothelial monocultures
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undergo a more efficient capillary formation in the presence of
angiogenic factors. Studies have shown that VEGF-releasing
hydrogels,42 hydrogels with covalently bound VEGF,43 and
hydrogels with covalently bound VEGF peptide mimetics44 are
all capable of inducing vascularization in otherwise inert
polyethylene glycol (PEG)-based systems. Strategies such as
these, along with adhesive properties and MMP sensitivity, have
been recently thoroughly reviewed.45
Alternatively, vascular networks will spontaneously form
when endothelial cells and appropriate mural cells are cultured
together within the hydrogel, with the mural cells providing
both angiogenic factors and, crucially, integrating with newly
formed vessels to stabilize and further mature nascent
vasculature.33,46 In addition to dissociated cells, the culturing
of aggregates of cells or explanted tissues within hydrogels has
enabled the study of angiogenesis, whereby vessels extend from
the aggregate into the surrounding gel.36,47 Known as the
sprouting assay, this is also used to study the process of
anastomosis where sprouting vessels connect with one another.
Again, the successful formation of sprouts requires either the
addition of growth factors or the presence of other supporting
cells types. These techniques to create 3D vascular in vitro
models have also been applied to the vascularization of tissue
scaffolds as a means to improve the viability of implanted
constructs48,49 or as cell-based angiogenic therapies for
treatment of tissues that have become ischemic, such as the
myocardium.50
Similar to the 3D culture platforms described above,
implantable tissues have been embedded within carrier
hydrogels in combination with supporting cells, such as
HUVECs and hMSCs, to encourage prevascularization and
promote anastomosis.51,52 However, this approach lacks control
over the size and distribution of vessel formation, risking
delayed anastomosis of the tissue and reduction in delivery of
oxygen and nutrients within the implant.
■ IMPORTANCE OF CELL PATTERNS
The strategies described above rely on the uncontrolled
addition of endothelial and supporting cells as a way to induce
vascularization within a TE construct, which poses some
limitations. With all cells having a random starting position,
vascular morphogenesis will be dependent on the spontaneous
self-organization of endothelial cells.24 Under this condition,
neovascularization seems to occur initially via the formation of
Figure 2. Shown are leading examples of materials based patterning of vascularization. (a) Control over the covalent photopatterning of RGD within
a degradable PEGDA based hydrogel has been shown to recapitulate biomimetic networks of vascularization.57 (b) Through judicious use of
photolabile protecting groups, the patterning of RGD sites within a hydrogel can be effected after fabrication of the hydrogel with success in directing
vascular formation subcutaneously in mice.58 Additionally, patterning of MMP cleavable hydrogels (c) with networks that are “permissive” and “non-
permissive” to cellular remodelling has shown to be an effect strategy for the directing the vascularization of ECFC clusters.59 In an interesting
example, complex gradients (d) of MMP cleavable cross-links, RGD concentration, and VGEF concentration have been shown to provide
directionality to the growth of vascular networks in hydrogel materials. Surprisingly, these vessels are formed bidirectionally along the gradient, i.e.,
high-to-low and low-to-high directionality.61 Scale bars: (a) 50, (c) 100, and (d) 200 μm.
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endothelial clusters in a vasculogenic-like process, followed by
extensive sprouting. Subsequently, vascular networks are
formed as a combination of sprout anastomoses or cluster
thinning.25 Although this results in vasculature, this is a time-
consuming process that might prove too slow to supply the
demands of a thick implant. Moreover, network formation
occurs in a random manner and is characterized by nonuniform
rate, length, diameter, and tubule orientation, which results in a
network with a tortuous morphology, dense interconnectivity,
and possibly distanced more than 200 μm from tissue-specific
cells.53 This random network also does not offer any clear
location for natural or surgical anastomosis, which may result in
delayed perfusion.24 Finally, in a natural setting, the blood flows
from macro- to microvessels, which allows the conservation of
shear rate at bifurcations, as described by Murray’s law. If the
shear rate falls below a certain threshold, which can occur when
parent and daughter vessels have the same diameter, thrombus
formation can occur and perfusion is lost. This problem has
been reported in a prevascularization strategy using unpat-
terned cell-embedded hydrogels.54
To address some of these problems, recent efforts have
focused on controlling cell localization as a strategy to improve
neovascularization within a TE construct. Cell-patterning
techniques bring several advantages. First, vessels can be
assembled faster. Second, patterning can direct vessels to
resemble the natural vascular tree in order to maintain a shear
rate above the thrombogenesis onset. Third, patterning can
recapitulate native vessel-tissue architecture (e.g., liver micro-
architecture) and to ensure its distribution complies with the
diffusion limit.53,8 Larger patterned structures, forming macro-
vessels, may provide clear locations for surgical anastomosis,
thus leading to a faster perfusion of the implant and good host
integration. Lastly, patterning techniques facilitate the combi-
nation of a bioreactor with a TE construct, in which an inlet/
outlet can be employed to dynamically seed cells, provide fluid
flow within the construct (essential step for vessel maturation),
and/or administer drugs until the point of implantation.55,10
The following sections will review different strategies to induce
vessel patterning through materials modification, structural
guidance, and direct cell deposition.
■ MATERIAL-INDUCED PATTERNING
The development of new materials has been pursued to direct
and to spatiotemporally control the formation of vascular
networks. Materials-based control of the vascular ingrowth at a
molecular level remains one of the most promising patterning
strategies. Toward this aim, several prominent materials-based
strategies have been successfully employed to guide and direct
vasculature formation in 2D and 3D space as depicted in Figure
2.
Currently, spatiotemporal control of vascularization is most
commonly effected through patterns of growth factors, adhesive
peptides (e.g., RGD), cross-link density and/or patterns of
MMP-degradable cross-links (Figure 1b)). As already dis-
cussed, growth factors such as VEGF have a direct influence on
both vasculogenic and angiogenic processes. Therefore, their
presentation to cells in predefined patterns can potentially
provide control for region-specific cell differentiation and over
sprouting direction. Sprouting angiogenesis anisotropy could
also be harnessed with patterning of cell adhesion peptides and
MMP-sensible cross-links, which are both required for
endothelial cell migration.
For example, Leslie-Barbick and co-workers56 demonstrated
that the photopatterning of covalently bound VEGF and RGD
within a PEG diacrylate (DA) hydrogel network directed the
formation of tubular-like endothelial cell organization with
significant upregulation of angiogenic genetic markers.
Exhibiting the ability of this approach to recapitulate complex
architectures, Culver and co-workers57 recorded the vasculature
of several model tissues (retina, cerebral cortex, and heart) via
confocal imaging and patterned into 3D hydrogels. Within an
MMP-cleavable PEGDA network, covalently bound RGD was
patterned via two-photon polymerization to match the
architecture of the tissue vasculature. When this patterning of
RGD was effected in hydrogels laden with HUVECs and 10T1/
2s fibroblast-like cells, the coculture organized into complex
tubule-like networks that overlaid remarkably well with the
biomimetic patterns (Figure 2a). In another work utilizing
RGD patterning, Lee and co-workers58 successfully transferred
a VEGF-containing hydrogel capable of inducing vasculo-
genesis42 into a photopatternable system capable of directing
vasculogenesis in vivo. Utilizing a caged RGD sequence
(photolabile 3-(4,5-dimethoxy-2-nitrophenyl)-2-butyl ester
(DMNPB)), they were able to exhibit spatial control over the
presentation of RGD and direct the migration of cells within
the biomaterial (Figure 2b). This system allows real-time
modification of the biomaterial; consequently, they showed that
spatiotemporal regulation of RGD presentation within VEGF-
containing hydrogels was able to direct vascularization to
specific locations of the hydrogel when implanted subcuta-
neously in mice.
In addition to the patterning of cell-adhesive molecules and
growth factors, spatial control over the degradation of the
material can also be utilized to guide vessel formation. In a
study by Hanjaya-Putra and co-workers,59 acrylated hyaluronic
acid (HA) was cross-linked with MMP-sensitive cross-links and
functionalized with RGD. In the absence of photopolymeriza-
tion, cell-remodelable hydrogels were formed that allowed
vasculogenesis, whereas photopolymerization created a non-
degradable network that blocked vasculogenesis in both in vitro
and in vivo models. Both hydrogels allowed vacuole and lumen
formation; however, the photo-cross-linked hydrogel did not
allow branching, sprouting, or network formation. By photo-
polymerizing sections of a hydrogel in the presence of a mask,
controlled and directed angiogenesis from ECFCs seeded on
top of the hydrogels was demonstrated (Figure 2c). In a step
toward selectivity of hydrogel remodeling for vascularization,
research to determine the effect of MMP cleavage-site
specificity on vascular ingrowth has shown promising results
in vitro, yet all materials showed similar results in vivo.60
Although the “off/on” patterning of materials has been
shown to enable directional vascularization within hydrogels,
the utilization of gradients within materials is less explored. In a
telling example, Turturro and co-workers61 fabricated PEGDA
hydrogels with concurrent gradients of stiffness, susceptibility
to MMP cleavage, and RGD density via a gradient polymer-
ization technique. When compared to bulk polymerized
hydrogels, those formed via gradient polymerization showed
increased directionality of formed vascular networks when
populated with HUVEC and human umbilical artery smooth
muscle cell (HUASMC) aggregates (Figure 2d). Interestingly,
in areas with the highest network density and highest
concentration of RGD, vascularization was affected along the
gradient of the material−vascularization occurred bidirection-
ally from high-to-low and low-to-high density areas. The exact
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mechanisms of this polarization are currently unknown, but
follow-up research has shown that stable gradients of VEGF
within hydrogels can consistently increase vascularization depth
in in vivo-implanted hydrogels relative to nongradient hydro-
gels.62 Using multiphoton laser patterning, Aizawa et al. created
a covalently bound gradient of VEGF within a hydrogel to
direct angiogenic activity.63 In addition, it is well-known that
gradients of oxygen concentration are able to direct
vascularization toward the hypoxic area.64 Gradients have
consistently been shown to affect the vascularization propensity
of hydrogels, but remain an underexplored and promising
variable to consider when engineering instructive materials for
tissue regeneration.
Much work remains to be done toward the spatiotemporal
control of vascularization within tissue-engineered constructs
and biomaterials. Although the above approaches have made
significant progress, specificity and selectivity are needed when
attempting to recreate vasculature within complex tissue with
multiple cell types. In this regard, gradients and/or patterning
of VEGF- or MMP-cleavable sites specific for vascularization
may be the most promising, because vascularization networks
will be competing with other cell types for adhesion and
proliferation.
■ STRUCTURE-INDUCED PATTERNING
To engineer a vascular pattern, a number of techniques have
evolved that produce structural patterns of microchannels,
which provide a designed 3D architecture to localize
endothelial cells and direct self-assembly of microvessel
networks. The beginning of this “structural patterning” can
be traced to the field of microfluidics, which employs rigid
microfabricated molds to transfer microchannel structures to
softer polymeric materials and create well-defined micro-
channels; a brief review by Kim et al. provides and overview
of the field.65 Although microfluidic devices are attractive tools
for vascularization studies (reviewed by Smith et al.66), they are
typically fabricated from polymers that do not mimic the native
biological environment. This has prompted the integration of
cell-laden hydrogels within microfluidic devices for an
improved in vivo approximation. Initial strategies relied on
vasculogenesis to create perfusable vessel networks,67−69
enabling the study of nutrient transport70 and revealing that
the application of flow itself can induce formation of
vasculature.71 Because these microvessels take time to develop
and are random in nature, various techniques aim to accelerate
the formation of designed vascular networks by incorporating
guiding microchannel structures within biomimetic hydrogels.
Such structures resemble the vessel lumens and once they are
populate with an endothelial cell layer, a vascular network
microarchitecture can be achieved much faster than through
random cell self-assembly. Figure 3 provides an overview of
these structure-induced patterning techniques, classified into
three main categories in the discussion below: layer-by-layer
film casting; removable template molding; sacrificial templating.
Layer-by-Layer Film Casting. The layer-by-layer approach
casts a polymer solution onto microfabricated molds to
produce a biocompatible hydrogel layer with microchannel
structures. These layers are then placed on top of a flat
substrate to form an enclosed, perfusable channel network.
Numerous hydrogel materials have been used to create
microfluidic devices, ranging from the bioinert alginate72 and
agarose73 (Figure 3a) to the intrinsically cell-adhesive fibrin and
collagen.74 These studies report microchannel sizes from 20
μm74 to 1000 μm,73 all of which have been shown to maintain
the viability of cells encapsulated within the bulk of the
hydrogel. This technique is particularly promising to recreate
Figure 3. Selected strategies for structure-induced vascularization. (a) Light micrograph cross sectional images showing channel fidelity and the
layer-by-layer interface between hydrogel films of agarose. (top left) A channel 50 um in width 70 um in height and (bottom left) 1 mm in width 150
um in depth are depicted. Diffusion over time of FITC-BSA into the surrounding agarose gel (right).73 (b) Extruded agarose “wires” are used to form
microchannel within gelatin (top), shown here with a perfusion of red microbeads in solution.79 (c) An alginate hydrogel formed in a PDMS mold is
embedded within gelatin and dissolved using EDTA, resulting in perfusable microchannels (right). A triple layer 3D microfluidic network in gelatin,
perfused with different colors (left).86 (d) A 3D printed sacrificial template of Pluronic F-127 is intercalated between bioprinted hMSCs and the
whole structure is embedded in a fibroblast-laden matrix. The sacrificial ink is then removed and the structure perfused with endothelial cells to
produce vasculature surrounding the parenchymal and stromal tissue.131 Scale bars: (b) 3 mm and (d) 1.5 mm.
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the in vivo setting of endothelialized vessels surrounded by
mural cells. Starting with fibrin or collagen gels laden with
mural cells, it has been shown that such microchannel systems
can be seeded with endothelial cells to form a structurally
patterned vessel-like organization.
Although traditional microfluidic materials can be bonded to
a substrate to create a sealed perfusable system, hydrogel films
must be either placed in a specialized apparatus that
mechanically maintains a seal75 or two gel surfaces must
undergo localized depolymerization, placed against one
another, and then repolymerized to form a bond.72−74 By
employing a microfabricated mold, precise and intricate designs
can be achieved of interconnected networks of microchannels
with a wide range of dimensions. However, this micromolding
approach intrinsically limits this technique to planar micro-
channels designs, in contrast to the arborized 3D vessel
structures observed in vivo. Furthermore, the cumbersome
assembly and sealing of such a layer-by-layer hydrogel device
restricts the broader application of this approach.
Removable Template Molding. Microchannels were first
formed within a monolithic hydrogel construct by forming the
gel around removable channel templates, such as wires or
needles (Figure 1c)). Acellular collagen gels formed in this way
have been used as nutrient beds, with emulated blood flow to
support multiple layers of cultured cells.76 This improved the
viability of thick (∼100 μm) layers of cells; endothelial cells
from the cell layer were shown to migrate and surround the
microchannels in a manner reminiscent of vasculature. Similar
devices made of gelatin methacrylate (GelMA), a photo-cross-
linkable collagen derivative, were shown to support both the
encapsulation of fibroblasts within the gel and the seeding of
endothelial cells within the microchannels for a more direct
recreation of vascular structures.77
The need to physically remove templates from fragile
hydrogels typically requires these molding structures to be
nonadherent, to be sufficiently large and strong enough to be
manually extracted. To preserve the integrity of the encasing
structure, most reported strategies employ channel templates
with a straight shape such as rigid wires or needles with
diameters ranging from 76 to 300 μm.77,78 In place of a novel
approach encapsulates flexible agarose “wires”, 250 to 1000 μm
in diameter, within GelMA79 (Figure 3b). Agarose does not
adhere to the gelatin and, at these diameters, has sufficient
strength to be manually extracted. Furthermore, channels with
slight curvatures are also possible. In this system, osteoblasts
were encapsulated within the GelMA and perfused endothelial
cells formed a monolayer on the microchannel wall. Jose ́ et al.
recently reported vessels with 45°-angled bifurcations can also
be patterned, by pulling out flexible polydimethylsiloxane
(PDMS) rods from a collagen medium. These materials do not
adhere to one another, permitting template removal and
formation of an open channel network that can be further
endothelialized.80
While the formation of microchannels via the methods
described can create endothelialized microchannel within a
single, monolithic segment of hydrogel, this cannot easily
realize an intricately designed, interconnected microchannel
networks as achieved through film casting. Furthermore, the
need to extract the removable molds restricts channel size and
limits design complexity.
Sacrificial Molding. A versatile alternative molding strategy
using a sacrificial template to create complex microchannel
networks. In this approach, the template structure is fabricated,
embedded within a hydrogel precursor, and later dissolved after
the hydrogel is cross-linked. Bellan et al. reported on the
formation of microchannels within a biocompatible gelatin
hydrogel construct, achieved by embedding Shellac microfibers
and later removing them via degradation in an ammonia bath.81
A more recent example employs water-soluble poly(vinyl
alcohol) (PVA) cast in a PDMS mold to form well-defined
sacrificial templates.82 This template was embedded within a
nonaqueous hydrogel precursor to prevent premature PVA
dissolution, followed by thorough washing with water and PBS
after cross-linking to extract any nonaqueous solvents and the
PVA template. A novel method of creating suitable sacrificial
template was reported by Huling et al.,83 where the preserved
vascular tissue of a mouse kidney was used to cast a
polycaprolactone (PCL) template. This template was later
coated with a layer of cross-linked collagen and the PCL was
dissolved with acetone. While unique in its recreation of the
arborized and multiscale vascular pattern, the final hollow 3D
structure of thin collagen restricted cell seeding to the outside
of the microchannel structures. In general, these approaches
require harsh conditions to form the microarchitecture, limiting
the introduction of cells to when device fabrication is complete.
To make sacrificial templates resilient to the aqueous
conditions of cell-laden hydrogels, a few studies have taken
water-soluble structures and coated them with a biocompatible
water-insoluble layer of poly(DL-lactide-co-glycolide)
(PDLGA).82,84 Miller et al., in particular, have elegantly
combined this approach with the 3D printing of an organized
lattice of carbohydrate glass microfilaments, ranging in size
from 150 to 750 μm.84 Although this study produced
microchannels in cell-laden hydrogels and reported angio-
genesis as endothelial cells within the channels invaded the
surrounding hydrogel, a major drawback of this approach is the
residual barrier of the PDLGA sheath on the microchannel
perimeter. To create microchannel structures without the use of
protective polymer layers or harsh dissolving agents, alginate
can be used as the sacrificial material. In a recent report, a cross-
linked alginate template was created, then disrupted using
either sodium citrate or alginate lyase, resulting in 40-μm
channels within a fibrin gel.85 This process retained the viability
of embedded cells dissociated from cardiac tissue, with the
endothelial cells of this mixed population observed to migrate
and populate the lumen of the microchannels. Ethylenediami-
netetraacetic acid (EDTA) has also been used to liquefy
alginate and form microchannels from 20 to 500 μm in
diameter with collagen, gelatin, or agarose86 (Figure 3c).
Although this approach is capable of multilayered 3D
microchannel architecture and supports the seeding of
endothelial cells within the microchannels to form vascular-
like structures, compatibility with embedded cells has not been
shown.
Solubilizing agents are avoided altogether by using sacrificial
templates that liquefy in response to temperature changes. One
study formed and embedded a gelatin template at room
temperature, later raising the temperature to 37 °C to liquefy
the gelatin and form microchannels.87 The embedding matrices
reported include collagen, Matrigel, and fibrinogen, with
fibroblasts hosted within the gels and endothelial cells perfused
within the channels. The gelatin templates were fabricated with
a PDMS mold, leading to microchannels ranging from 6 to 50
μm in width. Lee et al. have alternatively devised a poly(N-
isopropylacrylamide) (PNIPAM) template strategy that
requires cooling from 37 to 32 °C to liquefy and remove the
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template.88 This permits faster gelation at 37 °C for hydrogels
such as collagen or Matrigel, ensuring the viability and
homogeneous distribution of encapsulated cells. Although this
work reported microchannels ranging from 35 to 100 μm in
diameter and maintains the viability of encapsulated fibroblasts,
no seeding of endothelial cells was described. This could be
attributed to the highly random organization of the micro-
channel network produced, which could have hampered cell
seeding.
To achieve a more designed capillary network, thermores-
ponsive materials such as Pluronic F-127 can be printed directly
to fabricate a custom-designed sacrificial pattern with high-
fidelity. These patterns can also be printed in combination with
other cell-laden bioinks and further embedded within cell-
adhesive hydrogels, such as GelMA.89 Upon cooling to 4 °C,
the pluronic material undergoes gel-to-fluid transition, resulting
in an empty channel networks that offers precise locations for
perfusion with endothelial cells. Applying this strategy, Kolesky
et al. demonstrated its potential by fabricating a large and
vascularized tissue construct. Here, the authors used 3D
printing to pattern hMSCs in a lattice that was intercalated
with Pluronic F-127. These structures were further encapsu-
lated in a gelatin/fibrinogen mixture carrying human fibroblasts,
followed by fugitive ink removal and endothelialization of the
network (Figure 3d). To assess the vasculature functionality
and develop a bonelike construct, we perfused osteogenesis-
inducing biomolecules and the resulting expression of bone
markers evaluated. The vascularized scaffolds stained positively
for collagen type I and osteocalcin, and showed a much denser
formation of mineralized matrix compared to the avascular
control.10
Overall, sacrificial molding methods present a versatile
approach to create microchannel structures, but are generally
restricted to either planar or completely random networks. For
this reason, advances in bioprinting techniques hold great
promise in terms of improved 3D design capabilities and
integration with additional tissues
■ DIRECT CELL PATTERNING
Techniques that can control cell localization, from multicellular
clusters to single cells, have also been utilized in the
construction of vascular networks (Figure 4). These techniques
make use of the potential for cell self-assembly and autonomous
organization into blood vessels to generate vascular patterns.
Controlled cell deposition, such that cells are in close proximity
to one another, can decrease the time required for cellular self-
assembly while simultaneously guiding the direction of lumen
formation.90 Direct cell patterning technologies encompass cell
molding, 3D bioprinting, inkjet printing, laser-assisted bioprint-
ing (LAB), and optical guide/tweezers.
Cell-laden hydrogels are used in tissue micromolding
techniques to create geometrically defined and multiscale
vessels. Baranski et al. showed this by seeding a mixture of
HUVECs and fibroblasts in liquid collagen into 150-μm-wide
microchannels of a PDMS mold, where the cells would self-
assemble into vascular cords53 (Figure 4a). These were
subsequently peeled off and embedded in a fibrin hydrogel,
prior to implantation in mice. Patterning vasculature within the
construct proved to be beneficial, given that compared to the
randomly seeded construct, the former yielded a faster
anastomosis with the host, improved vascular network
formation, and required a fewer number of cells. Another
example was shown by Nikkhah et al., where photomasked
channel patterns were formed from cell-laden GelMA, resulting
in the formation of vascular cords with a diameter proportional
to the channel width.91 Micropatterning techniques, although
capable of providing precisely tuned vascular channels, require a
plastic support for their formation, which impedes the blend of
other tissues within the vasculature and does not provide the
ability to recapitulate multi- layered tissue organization.
Figure 4. Selected strategies for the fabrication of vascularization utilizing cell patterning. (a) Left: Schematic representation of the vascular cords
assembly through a micromolding technique. Right: Self-assembly of HUVECS and 10T1/2 fibroblasts into vascular cords happens within 10 h.53
(b) 3D printing of concentric multicellular cylinders (top left) enables the formation of a double-layered vascular tube (green represent SMCs and
red represents fibroblasts). Histological examination of the tubes after 3 days of fusion show H&E (top right), smooth muscle α-actin (brown,
bottom left), and Caspase-3 (brown, bottom right).95 (c) Free-from inkjet printing of sodium alginate and fibroblasts into a bath of calcium chloride
enables the fabrication of cell-laden tubular structures with bifurcations, creating well-defined tubular structures with vascular cell type.100 Scale bars:
(a) 50 μm and (c) 3 mm.
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A classical approach relies on the formation of spheroids,
multicellular aggregates that can be used as building blocks to
construct tissues.92 A simple demonstration for vessel assembly
consisted on casting vascular spheroids in collagen hydrogels to
induce vascular fusion.93 The VEGF-treated E8.5 mouse
allantois−derived spheroids fused together as coalescent
droplets, resulting in the formation of a single lumen and
SMCs layer. Control over spheroid location is crucial for
efficient vessel assembly, design, and integration with other
tissues. This can be provided by 3D bioprinting, which allows
for controlled extrusion of material to generate custom-made
patterns (Figure 1d). Jakab et al. reported the 3D bioprinting of
spheroids into collagen gels which served as support (biopaper)
for their assembly.94 However, uneven gelation and collagen
incorporation into the cellular construct led the researchers to
replace collagen with agarose95 (Figure 4b). Although using
spheroids for tissue formation is a simple approach, several
drawbacks exist, including the need for several spheroid units,
their large size (∼300 μm), long fusion times, and resulting
inhomogeneous structures.95 The slow kinetics of spheroid
fusion was probably due to the agarose substrate, because this
parameter has been described to depend on matrix chemical
and physical properties.5 To circumvent this, the same authors
used concentric multicellular cylinders composed of SMCs
(inner layer) and fibroblasts (outer layer) to fabricate a vascular
tube, representing a macrovessel with tunica media and
adventitia, which could be later perfused.
The assembly of vascular channels has been achieved by 3D
bioprinting approaches using both natural and synthetic
hydrogels as cell carriers. Cell extrusion within ECM-mimicking
biomaterials has also been achieved where fibroblasts were
encapsulated in gelatin or multiarm PEG, both premodified
with HA.96,97 Tubes were built either by vertically printing
around acellular layers of HA96 or by horizontal deposition on
agarose rods.97 3D bioprinting technologies may provide the
tools to assemble functional large- to medium-sized blood
vessels in vitro. However, generation of a dense microvascular
network resembling the native situation is yet to be
accomplished, as a consequence of the low resolution that
current systems offer.
In contrast to 3D bioprinters, inkjet printers have the
advantage of high resolution, delivering picoliter droplets with
an accuracy of a few micrometers.98 Both the thermal and piezo
modality have been used with some success to fabricate vessel-
like shapes.99,100 Fibrin strands containing HUVECs with a
width smaller than 100 μm could be formed by thermal inkjet
printing of a cell-thrombin solution within a fibrinogen
substrate.99 The cells proliferated, aligned in the channels,
and showed some integrity when patterned in ring structures.
Christensen et al. developed a more complex design that
featured a support-free construction of tube with bifurcations as
well as horizontal and vertical components100 (Figure 4c). One
drawback of inkjet printing systems is it requires low viscosity
Figure 5. Current approaches utilizing a combination of techniques for vascularization. (a) Fluorescence imaging of a printed vascular channel
fabricated in layer by layer deposition after 1 day of culture on dynamic flow conditions (top, HUVECs are shown in red, flow beads are shown in
green). Good monolayer formation is exhibited by fluorescence imaging of both cross sections of this channel (middle left and bottom left) and the
surface of the channel (bottom right, DAPI staining is blue, RFP-transfected HUVECs are red, VE-cadherin staining is green).109 (b) Fabrication of a
synthetic capillary via live cell lithography.106 Using optical tweezers and photopolymerizable hydrogels, clusters of different cell types can be
positioned with great precision and accuracy. (c) Supramolecular interactions allow self-healing and shear-thinning cell-laden materials.114 Here, one
cell-laden material (guest, red) can be printed into another cell-laden material (host, green) that deforms to accommodate the ink and self-heals to
maintain its position.Patterning.
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solutions to prevent nozzle clogging, thus limiting the choice of
materials and range of cell densities.98
These material restrictions are not an existing issue for LAB,
since it is a nozzle-free system and therefore allows the printing
of droplets with various viscosities (1−300 mPa/s) and cell
densities.8 LAB has been used to pattern a microvascular
network with a stem and branches composed of HUVECs.101
After 1 day of culture, the cells were seen to stretch out and
establish connections with each other that resulted in lumen
formation. Lumen size could be controlled by varying the
distance between cell deposition and, thus, the cell density per
unit area. However, these HUVEC networks were unstable and
dissociated after a few days in culture, which could be
prevented by depositing juxtaposed SMCs 1 day after
HUVEC printing. Despite the accuracy attained with a LAB
setup, the resulting construct was still too thin for use in a
clinical setting. In another report, these authors showed that
thicker scaffolds (300 μm) could be built by printing HUVECs
on top of porous poly(DL-lactide-co-glycolide) biopaper coated
with Matrigel.102 Stacking these layers into a thick and
functional construct that can be perfused remains to be
demonstrated. Despite these successes, LAB suffers from
several issues, such as the generation of metallic residues
during printing, inhomogeneous cell deposition, and long
process duration.
Lastly, optical trapping systems can be used as vessel
assembly tools by allowing the contactless manipulation of
individual vascular-specific cells into defined positions.
Compared to the above-mentioned techniques, optical systems
offer unmatched precision to control cell location, a great
benefit when recreating the multicellular context of vasculature
and surrounding tissues. Hocheng et al. provided the proof-of-
concept for optical trapping: endothelial cells were guided by
laser through microchannels toward a construction area, where
cells could be entrapped by laser tweezers and moved in the
horizontal or vertical axis.103 Some efforts have been made to
further develop this technology, such as inclusion of
biomaterials and perfusion systems, to make it a viable
technique.
■ ADDRESSING LIMITATIONS
Despite substantial progress over the past ten years in the
vascularization of biomaterials and artificial tissues, obstacles
still remain to produce viable, complex and large implants. We
have a working understanding of the major signaling molecules,
necessary cell types, and ECM properties that both inhibit and
promote vascularization. However, the majority of these studies
address only the beginning of a complex problem. How do we
control the vascularization of multicellular engineered tissue?
Within this framework, we propose that three major limitations
remain:
(1) scalability of prevascularized multicellular engineered
tissues
(2) directing and connecting vascular networks of multiple
length scale
(3) directing vascularization in the presence of other cell
types
As researchers continue to strive to find the best engineering
solution for organ assembly and vascularization, a synergy of
technologies will be likely required to overcome existing
limitations (Figure 1e). The combined development materials
and fabrication strategies will be essential in addressing these
issues, with a number of existing examples shown in Figure 5.
This is clearly evident in microfluidic approaches, which have
provided powerful tools to simplistically decode physiological
processes and assemble tissue functional units (e.g lung-on-a-
chip104, liver sinusoid-on-a-chip105) but have failed to
reproduce the native microarchitecture, spatial heterogeneity,
and cell−matrix interactions.106
To recreate multicellular structures with high fidelity,
Sarveswaran et al. recently showcased a combined approach
to build a human capillary.106 Using live cell lithography,
vascular cells were entrapped in photopolymerizable hydrogels
to create living voxels, which could be stitched together into a
single structure. The cell positioning, ratio between different
cell types, and embedding material could be finely tuned in
order to recreate the cellular architecture and mechanistic
environment present in a human blood vessel. This method
provided an unprecedented control for the generation of TE
constructs, albeit at a much lower scale than the required to
create whole organs (Figure 5b). Zhang et al. have also
showcased an elegant microfluidic platform to assemble
miniature vascularized and functional tissues.107 Referred to
as the AngioChip, this engineered platform combines a 3D
biodegradable and porous scaffold with a classic microfluidic
chip. A 3D stamped poly(octamethylene maleate (anhydridre)
citrate) (POMaC) microchannel network is assembled within
the chip and perfused with endothelial cells in order to form
built-in patterned vasculature. Surrounding this rigid structure,
a cell-loaded ECM gel (collagen/Matrigel mixture or fibrin)
forms the parenchymal space. Several combinations of the
vascular phase and involving medium can be achieved, making
this a highly versatile platform for organ-on-a-chip engineering.
This concept was applied to build a liver construct with drug
metabolizing capability and a contractile cardiac tissue
responsive to chronotropic stimuli (epinephrine injection).
Surgical anastomosis of the chip showcased the ability to
sustain native blood circulation and the scalability of this
platform to create a human-sized constructs, unique for a
microfluidic approach.
With respect to scalability, 3D bioprinting techniques are
more advantageous and still allow for an easier custom-design
fabrication. An example of this is demonstrated by Kang et al.,
who devised a 3D printing system incorporating cell-laden
hydrogels, sacrificial hydrogels, and biodegradable solid
polymers to yield human-scaled tissue constructs with
anatomical shape and mechanical integrity. Bone and skeletal
muscle tissue replacements were fabricated and implanted, but
vascularization within the constructs still relied on capillary
invasion from the host, which limits the applicability of this
system.1 As previously discussed, other works have already
demonstrated the potential of 3D printing techniques to
pattern vasculature, either through fabrication of vessel
templates and subsequent endothelialization10,108 or direct
deposition of cells.95 In a mixed approach, Lee et al. bioprinted
a layer of HUVECs/gelatin mixture between a collagen
support, which was thereafter liquefied and perfused, leaving
behind a cell lining at the materials interface109 (Figure 5a).
Addressing the need for multiscale vessels within TE
constructs, the same authors reported a variation of this
method, by printing and perfusing two large parallel vessels
separated by a HUVEC/fibrin mixture, where microvessels
spontaneously assembled and integrated with the parent
vessels.110
ACS Biomaterials Science & Engineering Review
DOI: 10.1021/acsbiomaterials.6b00269
ACS Biomater. Sci. Eng. 2016, 2, 1694−1709
1703
Despite these advances, 3D bioprinting techniques can also
benefit from improvements during the printing process.
Although typically a single hydrogel material is used as a cell
carrier, Colosi et al. devised an ingenious system that connects
a coaxial nozzle to a microfluidic printhead where two different
materials can flow, thus allowing for heterogenic fiber
deposition.111 A HUVEC-loaded GelMA/alginate bioink was
extruded through the inner nozzle and cross-linked via calcium
chloride flow from the outer nozzle and postprinting UV
irradiation. Over culture time, endothelial tubular structures
formed as alginate dissolves within the bulk of cross-linked
GelMA and cells migrate toward the periphery.
Although the existing palette of bioinks offers several
possibilities, the development of new extrudable materials,
such as polymers that form dynamic molecular networks, will
significantly contribute to progress. An example are supra-
molecular hydrogels, which have been recently investigated in
3D printing applications, mainly due to their interesting
characteristics such as shear-thinning and self-healing ability.
The spider silk hydrogels reported by Schacht et al.112 or the
guest−host HA hydrogels developed by Burdick’s group113
provide good illustrations of this new materials with reversible
supramolecular interactions. Using the latter hydrogels, the
ability to print cell-laden layers into a cell-containing self-
healing construct was demonstrated114 (Figure 5c). Within this
approach, the authors showed the possibility to print
connecting networks and to perfuse these printed networks, if
desired. Through direct printing within hydrogels, intricate
structures such as overhangs can be designed and held in place,
in contrast to classical bioprinting where the fluid−air interface
would lead to material collapse. Systems of supporting
hydrogels to accommodate printed inks are not restricted to
supramolecular materials, and others examples include alginate,
fibrin, or collagen in a gelatin support115 or collagen in a
Carbopol granular medium.116
One of the most significant hurdles in recapitulating and
mimicking the vascularization of natural tissues is the control
needed to create an open vascular network over multiple length
scales. Small scale of microvessels lie beyond the resolution of
physical patterning techniques, leading researchers to harness
the highly complex process of neovascularization as it occurs in
vivo. Although we are only beginning to unravel mechanisms to
direct it within an engineered tissue, a promising strategy is to
rely on gradients within materials or materials patterning for the
direction of capillary formation. Currently, a limited number of
materials can be tailored for vascularization control in 3D. PEG-
based systems dominate the studies due mainly to their ease of
synthesis and synthetic addressability. Unfortunately, PEG
acrylate systems are not always ideal, especially when
attempting to combine multiple fabrication methods. Novel
approaches to create hydrogels based on more biomimetic
networks including noncovalent interactions, self-assembled
structures, and reversible covalent bonds can all overcome the
limitations of a static covalent network.
Although these strategies can create small-scale vascular
networks that are perfusable and highly distributed for ideal
distribution of nutrients and oxygen,117 connecting such
networks to an organism’s vasculature remains a challenge;
recent studies have shown that natural anastomosis of
prevascularized implants results in a 7-day delay in functional
blood flow.52,118 This is attributed to the time-consuming
“wrapping and tapping” process of anastomosis119 and
subsequent delays associated with the clearance of blood clots
that result from initial contact between the host blood and
prevascularized vessels.52 A more rapid approach is to surgically
anastomosize engineered vasculature, which has been reported
as a viable option to rapidly promote integration with host
vasculature.120,121 While immediate blood flow can be
established, this requires a suitably sized vessel in order to be
compatible with the surgical procedure. Therefore, in order to
ensure viability and function of an implanted tissue construct, a
designed interconnected vasculature will be required that spans
many orders of magnitude.
The ability to control the vascularization of a tissue or
material in the presence of multiple cell types remains to be
demonstrated. Patterning and/or gradients of VEGF remain a
promising strategy for direction of solely vascular formation.
Little is known about the effects of controlling vascularization
with coculture of other cell types. This is a promising new area
of research that can give great insight into the regeneration of
complex tissue. Future research will certainly elucidate how to
efficiently blend technologies and material resources in this
quest for tissue and organ replacements.
■ FUTURE OUTLOOK
While some of the fabrication methods reviewed here require
specialized technological expertise and equipment, many of the
strategies are robust with low technical overhead. This includes
the facile method for microvessel patterning using a sacrificial
template of micromolded gelatin87 as well as the production of
microvascular spheroids and their assembly into larger vascular
structures. Prompted by the scientific opportunities of
“designer” vascular architecture, we foresee the widespread
adoption of these platforms through a combination of further
simplification of the fabrication processes and commercial
availability, mirroring the proliferation of microfluidic technol-
ogy. Similar to the introduction of 3D assays over 30 years
ago,122 these tools will allow us to further elucidate the
vascularization process under more controlled conditions to
provide both scientific insight as well as strategies to address
diseased or damaged tissues. In particular, methods able to
design endothelialized channel structures within a 3D multi-
cellular context provide a new way to study the interactions
between the vascular system and other cell types or tissues.
This includes investigating pathologies: designed vascular
models have facilitated the study of extravasation and
intravasation processes that enable cancer cells to penetrate
the vascular wall and metastasize.123,124 Impaired interactions
between vasculature and the nervous system have also been
implicated in certain pathological disorders,125 including the
role of disrupted cerebral neurovascular coupling in the
progression of Alzheimer’s disease.126 Current methods to
study this neurovascular coupling rely on in vivo models,
explanted cortical tissues, or dissociated in vitro cultures,
providing fertile ground for the development of multicellular
vascularized platforms as described in this review.
As these techniques evolve, the most immediate clinical
impact will come from a combination of methods to create a
meaningful, multiscale vascularization strategy for tissue
engineering and regenerative medicine. An ideal combination
of micron-sized capillaries (achieved with “smart” materials)
with highly arborized 3D distribution of slight larger micro-
vessels (via 3D cell printing) will ensure sufficient delivery of
nutrients; larger connected structures on the millimeter scale
(formed by molding techniques) would provide an ideal means
of surgically connecting this vascular tree to the blood supply of
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a patient. The ability to control the size and placement of these
vascular structures will also ensure proportioned blood flow
throughout. Initial steps toward such combinatorial approaches
have been showcased.127
The advent of more advanced 3D printing technology will
usher in immense potential within the biological and
biomedical sciences. As technology and materials continue to
evolve, we come closer to emulating the biological complexities
we observe in vivo. A major limitation in realizing these more
advanced printing technologies is the lack of suitable printable
materials to control and mimic the natural ECM. Only a few
well-characterized synthetic hydrogel systems exist, while many
are in their infancy of development. In particular, the dynamic
environment of the ECM is often lost in static, covalent
polymer hydrogels. Current advances in supramolecular
hydrogels and those formed by dynamic covalent chemistry
will provide new opportunities for self-healing materials that
will allow temporal control of hydrogel properties. With new
dynamic gel systems, “smart” materials will introduce dynamic
3D printing, whereby complex multicellular organization can be
realized in both a spatial and temporal manner. This advance
will enable maturation of vasculature, which is more effective
when the inclusion of mural cells is delayed,128 followed by the
introduction of functional cellular assemblies once the vascular
nutrient supply has been established. This also sets the stage for
actively recreating time-dependent developmental and self-
organizing processes, such as those observed for bone129 and
cartilage.130
The creation of appropriate vascular networks has long been
identified as the challenge that underpins the success of any
potential TE strategy. As described above and summarized in
Table 1, numerous approaches have been developed toward
meeting this challenge. The vascular network is one but of
many within the body. While it has become the most popular,
neural network regeneration, hepatic portal regeneration, and
kidney network regeneration can all benefit from the strategies
developed around neovascularization. Without the successful
control and engineering of the underlying networks that enable
viable tissue, TE and RM cannot progress. Furthermore, the
development of increasingly powerful and flexible technological
solutions extend far beyond simple vascularization, paving the
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